Infant formula meeting canceled
This article was originally published in The Tan Sheet
Executive Summary
FDA Food Advisory Committee meeting on infant formula scheduled for June 20-21 was canceled due to unavailability of some speakers, agency says. Meeting was to be second in series on quality issues ("1The Tan Sheet" June 3, 2002, In Brief). Rescheduling is planned, but dates have yet to be determined...You may also be interested in...
FAC infant formula, take two
Roche Continues To Make The Case For Gantenerumab In Alzheimer’s Disease
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.
Brinavess' US Review: EU Postmarket Data Unlikely To Save Troubled AFib Drug
Correvio's atrial fibrillation drug Brinavess will return to a US FDA advisory committee more than a decade after the agency first declined to approve the drug; FDA still has a series of cardiovascular safety concerns related to the drug and is not convinced by data from the European experience.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: